November 25, 2025
5 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
ORLANDO — In this video from the American Academy of Ophthalmology meeting, Arshad M. Khanani, MD, MA, FASRS, discusses developments in the treatment of neovascular age-related macular degeneration.Khanani delved into tyrosine kinase inhibitors, including the SOL-1 and SOL-R trials evaluating OTX-TKI (axitinib implant, Ocular Therapeutix) in neovascular AMD and the LUCIA and LUGANO studies
November 25, 2025
5 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

In this video, Anat Loewenstein, MD, MHA, of Tel Aviv Medical Center, Israel, highlights information presented at the American…

ORLANDO — In this video, David A. Eichenbaum, MD, FASRS, discusses late-stage wet age-related macular degeneration assets…

ORLANDO — In this video from the American Academy of Ophthalmology meeting, David A. Eichenbaum, MD, FASRS, discusses how…

LONG BEACH, Calif. — In this video from the American Society of Retina Specialists annual meeting, Arshad M. Khanani, MD, MA,…

In this Healio video, Christopher Lock, MD, discusses highlights in anti-amyloid therapies for Alzheimer’s disease presented at…

A one-time injection of ABBV-RGX-314, a gene therapy for wet age-related macular degeneration, yielded reductions in treatment…